Remus Pharmaceuticals IPO GMP, Review, Price, Allotment

0

Last updated on July 15, 2023

Remus Pharmaceuticals IPO GMP

Remus Pharmaceuticals IPO description – Incorporated in 2015, Remus Pharmaceuticals is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. It also deals in API (Active Pharmaceutical Ingredient). The company also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries.

The company has cultivated strong and dependable customer relationships ranging from generic distributors, regional distributors, and multinational distributors to Hospitals and Clinics through a responsive distribution network. Remus’ clients are spread in more than 20 countries and its product portfolio consisted of 429 products, as on 31 January 2023.

Remus Pharmaceuticals deals in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

Remus Pharmaceuticals 2023

Promoters of Remus Pharmaceuticals – Mr. Arpit Deepakkumar Shah, Ms. Roma Vinodbhai Shah, Mr. Swapnil Jatinbhai Shah and Mrs. Anar Swapnil Shah


Remus Pharmaceuticals IPO Details

Remus Pharmaceuticals IPO Dates17 – 19 May 2023
Remus Pharmaceuticals IPO PriceINR 1,150 – 1,229 per share
Fresh issue3,88,000 shares (INR 44.62 – 47.69 crores)
Offer For SaleNil
Total IPO size3,88,000 shares (INR 44.62 – 47.69 crores)
Minimum bid (lot size)100 shares (INR 122,900)
Face Value INR 10 per share
Retail Allocation35%
Listing OnNSE SME

Remus Pharmaceuticals Financial Performance

 FY 2020FY 2021FY 20229M FY 2023
Revenue11.9218.4224.7232.39
Expenses11.6717.8720.8924.92
Net income0.811.033.396.44
Figures in INR crores unless specified otherwise

Remus Pharmaceuticals Offer News


Remus Pharmaceuticals Valuations & Margins

FY 2020FY 2021FY 2022
EPS8.1210.2633.86
PE ratio33.96 – 36.30
RONW (%)40.1733.6852.64
NAV64.32
ROCE (%)47.7641.9069.99
EBITDA (%)10.428.5119.38
Debt/Equity0.180.090.03
*Compiled by IPO Central from Prospectus

Remus Pharmaceuticals IPO GMP Today

DateConsolidated IPO GMPKostakSubject to Sauda
26 May 20238230,000
25 May 20238027,000
24 May 20238027,000
23 May 20238025,000
22 May 20239015,000
20 May 20239512,000
19 May 202311015,000
18 May 202312015,000
17 May 202312515,000
16 May 202312012,000
15 May 202313015,000
12 May 2023135
11 May 2023150

Remus Pharmaceuticals IPO Subscription – Live Updates

CategoryQIBNon retailRetailTotal
Shares Offered73,70074,800129,000277,500
19 May 202320.24127.5936.1956.59
18 May 20232.612.957.424.94
17 May 20230.000.170.780.41

Remus Pharmaceuticals Offer Lead Manager

BEELINE CAPITAL ADVISORS PRIVATE LIMITED
807, Phoenix, Opp. Girish Cold Drinks,
Near Vijay Cross Roads, Navrangpura, Ahmedabad -380009
Phone: 079 4840 5357
Email: [email protected]
Website: www.beelinemb.com


Remus Pharmaceuticals Offer Registrar

LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park,
Lal Bahadur Shastri Marg, Vikhroli (West),
Mumbai, Maharashtra, India – 400 083
Phone: +91 810 811 4949
Email: [email protected]
Website: www.linkintime.co.in


Remus Pharmaceuticals Contact Details

REMUS PHARMACEUTICALS LIMITED
1101 to 1103, South Tower, One 42,
B/H Ashok Vatika, Nr. Jayantilal Park BRTS,
Ambli Bopal Road, Ahmedabad – 380054, Gujarat
Phone: +079- 2999 9857
E-mail: [email protected]
Website: www.remuspharma.com


Remus Pharmaceuticals IPO Allotment Status

Remus Pharmaceuticals IPO allotment status is now available on Link Intime’s website. Click on Link Intime IPO weblink to get allotment status.


Remus Pharmaceuticals IPO Dates & Listing Performance

IPO Opening Date17 May 2023
IPO Closing Date19 May 2023
Finalization of Basis of Allotment24 May 2023
Initiation of refunds25 May 2023
Transfer of shares to demat accounts26 May 2023
Remus Pharmaceuticals IPO Listing Date29 May 2023
Opening Price on NSE SMEINR 1,711.25 per share (up 39.24%)
Closing Price on NSE SMEINR 1,796.80 per share (up 46.20%)

Read Also: Nifty Pharma Stocks List With Weightage in 2023

Remus Pharmaceuticals IPO FAQs

What is the Remus Pharmaceuticals offer size?

Remus Pharmaceuticals offer size is INR 44.62 – 47.69 crores.

What is the Remus Pharmaceuticals IPO Price Band?

Remus Pharmaceuticals public offer price is INR 1,150 – 1,229 per share.

What is the lot size of the Remus Pharmaceuticals IPO?

Remus Pharmaceuticals offer a lot size is 100 shares.

What is Remus Pharmaceuticals IPO GMP today?

Remus Pharmaceuticals IPO GMP today is INR 82 per share.

What is the Remus Pharmaceuticals kostak rate today?

Remus Pharmaceuticals kostak rate today is NA per application.

What is Remus Pharmaceuticals Subject to Sauda rate today?

Remus Pharmaceuticals Subject to Sauda rate today is INR 30,000 per application.

LEAVE A REPLY

Please enter your comment!
Please enter your name here